Loading...
Loading...
In a report published Friday, Deutsche Bank reiterated its Buy rating on Vanguard Health Systems
VHS, and raised its price target from $17.00 to $19.00.
Deutsche Bank noted, “Fiscal Q2 wrap - VHS delivered in-line FQ2 EBITDA, and we believe it remains on track to meet FY 2013 guidance for $550-$575M in EBITDA. At the mid-point, EBITDA growth over FY 2012 would be +4%, which highlights good operational flexibility given $50M of annualized pressure in Arizona, Medicare sequestration and lower HITECH EHR payments yoy. Our 2014 EBITDA est was raised slightly in a ‘First Blush' note published earlier today; we based the increase primarily due to higher health plan contribution. And in light of slightly higher out-year EBITDA and lower net debt vs. FQ1 due to good CFFO, our 6.2x EV/EBITDA multiple brings the PT to $19 from $17; reiterate Buy.”
Vanguard Health Systems closed on Thursday at $13.97.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in